Cita APA

Guerrero Zotano, Á., Belli, S., Zielinski, C., Gil Gil, M., Fernández Serra, A., Ruíz Borrego, M., . . . Martín, M. (2023). CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2−Metastatic Breast Cancer.

Citación estilo Chicago

Guerrero Zotano, Ángel, et al. CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2−Metastatic Breast Cancer. 2023.

Cita MLA

Guerrero Zotano, Ángel, et al. CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2−Metastatic Breast Cancer. 2023.